The global chondroitin sulfate market size was valued at US$ 1249.4 million in 2022 and is anticipated to witness a compound annual growth rate (CAGR) of 3.1% from 2023 to 2030. The chondroitin sulfate market is projected to grow at a significant rate during the forecast period owing to the growing incidence of rheumatoid arthritis, osteoarthritis, and other chronic diseases. Additionally, the rising demand for nutraceutical products in developing economies due to rising health concerns is further anticipated to boost the market growth.
Global Chondroitin Sulfate Market Trends:
New product launch due to ongoing innovation
Key players are introducing non-animal source chondroitin sulfate in order to meet the growing demand. This is expected to propel the market growth. For instance, In May 2018, GNOSIS S.p.A. launched synthetic chondroitin sulfate worldwide. The company is involved in the production of chondroitin sulfate product from non-animal source under the brand name Mythocondro as a nutritional supplement to support human and animal health.
Growing health and wellness trend
With the growing prevalence of chronic disease and increasing adoption of healthy lifestyle among consumer, the demand for dietary supplements are gaining popularity. Chondroitin sulfate is used to treat this joint related condition by slowing its progression and making the pain and inflammation less severe. It is a key ingredient in some dietary supplements for joint health. In addition, more research is being done to explore the use of chondroitin sulfate in the treatment of other conditions, such as cardiovascular disease and cancer.
Chondroitin Sulfate Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients